Abstract
Purpose
Small intestinal cancers have a non-specific clinical presentation and hence a delayed diagnosis. The prevalence of small intestinal cancers is low, and there are no cost-effective methods of screening. This study aimed to identify clinical characteristics of duodenal and jejunal adenocarcinomas that can assist in the early detection and diagnosis of disease.
Methods
Duodenal adenocarcinoma and jejunal adenocarcinoma in Explorys database (1999–2019) were compared using odds ratio (OR) with 95% confidence intervals. Data on demographic characteristics, risk factors, clinical features, and treatment were collected.
Results
Out of a total of 8100 patients with a diagnosis of primary adenocarcinoma of the small intestine, 5110 are primary adenocarcinoma of duodenum (63%), and 600 are primary adenocarcinoma of jejunum (7.4%). Patients with jejunal adenocarcinoma when compared with patients with duodenal adenocarcinoma are more obese (OR, 1.36) and have a significantly higher prevalence of malignant neoplasm of colon (OR, 3.07), Crohn’s disease (OR, 4.42), and celiac disease (OR, 2.48). Jejunal adenocarcinoma patients presented more frequently with intestinal obstruction (OR, 1.99), whereas duodenal adenocarcinoma patients more commonly presented with iron deficiency anemia (OR, 0.16). Patients with jejunal adenocarcinoma are less likely to undergo therapy with anti-neoplastic agents when compared with duodenal adenocarcinoma (OR, 0.81). There are no differences in patients undergoing surgical intervention or a combination of surgical intervention and antineoplastic therapy.
Conclusions
Jejunal adenocarcinoma is more commonly associated with colorectal cancer, celiac disease, and Crohn’s disease. They also had lower odds of requiring chemotherapeutic agents.
Similar content being viewed by others
Availability of Data and Materials
All data and material related to the manuscript have been included with the manuscript.
References
Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249:63–71.
Key Statistics for Small Intestine Cancer [Internet]. 2020. Available from: https://www.cancer.org/cancer/small-intestine-cancer/about/what-is-key-statistics.html.
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. editors. AJCC Cancer Staging Manual [Internet]. 8th ed. Springer International Publishing. 2017. [cited 2020 Nov 6]. Available from: https://www.springer.com/gp/book/9783319406176.
Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF. A single-institution experience with 491 cases of small bowel adenocarcinoma. Am J Surg. 2010;199:797–803.
Sakae H, Kanzaki H, Nasu J, Akimoto Y, Matsueda K, Yoshioka M, et al. The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational study. Br J Cancer. 2017;117:1607–13.
Zhang Z-H, Qiu C-H, Li Y. Different roles of capsule endoscopy and double-balloon enteroscopy in obscure small intestinal diseases. World J Gastroenterol. 2015;21:7297–304.
Legué LM, Bernards N, Gerritse SL, van Oudheusden TR, de Hingh IHJT, Creemers G-JM, et al. Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands. Acta Oncol. 2016;55:1183–9.
Schottenfeld D, Beebe-Dimmer JL, Vigneau FD. The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol. 2009;19:58–69.
Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control. 2005;16:781–7.
Goodman MT, Matsuno RK, Shvetsov YB. Racial and ethnic variation in the incidence of small-bowel cancer subtypes in the United States, 1995–2008. Dis Colon Rectum. 2013;56:441–8.
Aparicio T, Henriques J, Manfredi S, Tougeron D, Bouché O, Pezet D, et al. Small bowel adenocarcinoma: results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients. Int J Cancer. 2020;147:967–77.
Boffetta P, Hazelton WD, Chen Y, Sinha R, Inoue M, Gao YT, et al. Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine–a pooled analysis of over 500,000 subjects in the Asia Cohort Consortium. Ann Oncol. 2012;23:1894–8.
Bennett CM, Coleman HG, Veal PG, Cantwell MM, Lau CCL, Murray LJ. Lifestyle factors and small intestine adenocarcinoma risk: a systematic review and meta-analysis. Cancer Epidemiol. 2015;39:265–73.
Palascak-Juif V, Bouvier AM, Cosnes J, Flourié B, Bouché O, Cadiot G, et al. Small bowel adenocarcinoma in patients with Crohn’s disease compared with small bowel adenocarcinoma de novo. Inflamm Bowel Dis. 2005;11:828–32.
Elriz K, Carrat F, Carbonnel F, Marthey L, Bouvier AM, Beaugerie L, et al. Incidence, presentation, and prognosis of small bowel adenocarcinoma in patients with small bowel Crohn’s disease: a prospective observational study. Inflamm Bowel Dis. 2013;19:1823–6.
Han Y, Chen W, Li P, Ye J. Association between coeliac disease and risk of any malignancy and gastrointestinal malignancy: a meta-analysis. Medicine (Baltimore). 2015;94:e1612.
Ursi P, Tarallo M, Crocetti D, Cavallaro G, Fiori E, D’Andrea V, et al. Second jejunal loop adenocarcinoma associated with celiac disease: the first case report. G Chir. 2019;40:225–9.
Vecchio R, Marchese S, Gangemi P, Alongi G, Ferla F, Spataro C, et al. Laparoscopic treatment of mucinous adenocarcinoma of jejunum associated with celiac disease. Case report G Chir. 2012;33:126–8.
Bridge MF, Perzin KH. Primary adenocarcinoma of the jejunum and ileum. A clinicopathologic study Cancer. 1975;36:1876–87.
Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101:518–26.
Talamonti MS, Goetz LH, Rao S, Joehl RJ. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg. 2002;137:564–70; discussion 570–571.
Nakanoko T, Koga T, Taketani K, Hirayama Y, Yoshiya S, Minagawa R, et al. Characteristics and treatment strategies for small bowel adenocarcinoma in advanced-stage cases. Anticancer Res. 2015;35:4135–8.
Duerr D, Ellard S, Zhai Y, Taylor M, Rao S. A retrospective review of chemotherapy for patients with small bowel adenocarcinoma in British Columbia. J Cancer. 2016;7:2290–5.
Overman MJ, Kopetz S, Lin E, Abbruzzese JL, Wolff RA. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. Acta Oncol. 2010;49:474–9.
Author information
Authors and Affiliations
Contributions
All the authors contributed to the study conception and design. Abdul Mohammed, Sophie Trujillo, and Sara Ghoneim performed the material preparation, analysis, and preparation of the manuscript. Critical review of the manuscript and final editing were performed by Neethi Paranji and Nisheet Waghray. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics Approval
This is an observational study. The MetroHealth Research Ethics Committee has confirmed that no ethical approval is required.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mohammed, A., Trujillo, S., Ghoneim, S. et al. Small Bowel Adenocarcinoma: a Nationwide Population-Based Study. J Gastrointest Canc 54, 67–72 (2023). https://doi.org/10.1007/s12029-021-00653-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-021-00653-7